Ua hoʻolaha ʻo Moderna, i kēia lā ua hoʻopuka ka Ministry of Food and Drug Safety of Korea (MFDS) i kahi mana kūʻai aku no Spikevax®, ʻo Moderna's COVID-19 vaccine (mRNA-1273) i hana ʻia e Samsung Biologics, kahi CDMO honua alakaʻi e hāʻawi ana i ka hopena hoʻohui piha. hoʻopau ʻaelike hoʻomohala a me nā lawelawe hana.
ʻO kēia ʻae kūʻai kūʻai i loaʻa e Moderna Korea e ʻae i ka lāʻau lapaʻau ʻo Moderna's COVID-19 i hana ʻia ma nā hale hana lāʻau lapaʻau kūloko o Samsung Biologics e kahele ʻia i loko o Korea a lawe ʻia aku i nā ʻāina ʻē aʻe.
Ua noi ʻo Moderna Korea no ka mana kūʻai kūʻai piha no Spikevax® me ka MFDS i ka hoʻomaka ʻana o Nowemapa a loaʻa iā ia i loko o hoʻokahi mahina.
Ua ʻae ʻo Philippines a me Kolombia i ka hoʻohana ʻana i ka hoʻohana ʻana i ka lāʻau lapaʻau Moderna COVID-19 i hana ʻia e Samsung Biologics ma Nowemapa 26 a me Dekemaba 2.
"Mahalo mākou i ka Ministry of Food and Drug Safety o Korea no kā lākou hoʻoholo e ʻae i kēia mana kūʻai. ʻO kā mākou hui pū ʻana me Samsung Biologics no ka hoʻopiha piha ʻana a me ka hoʻopau ʻana i ka lāʻau lapaʻau ʻo Moderna COVID-19 ke kōkua nei iā mākou e hoʻomau i ka hoʻonui ʻana i kā mākou hana hana ma waho o ka US, "wahi a Stéphane Bancel, Luna Nui o Moderna. "Me kā mākou mau hoa hana, hoʻomau mākou i ka lanakila ʻana i ka maʻi maʻi COVID-19."
"He mea koʻikoʻi maoli kēia no ka mea hiki iā mākou ke hoʻolalelale i ke kaʻina ʻae ʻia i ka launa pū ʻana me ke aupuni Korea a me Moderna, ʻoi aku hoʻi ma lalo o ka hoʻopaʻa ʻana o ka MFDS no ka hana mua ʻana i nā maʻi mRNA ma Korea," wahi a John. Rim, Luna Nui o Samsung Biologics. "Haʻaheo nō hoʻi mākou i ka hōʻike ʻana i kā mākou kūpaʻa i ka hoʻolako ʻana i ka maikaʻi a me ka wikiwiki i kā mākou kaʻina hana, a e hoʻomau i ka hana pū me kā mākou mea kūʻai aku e hoʻolako paʻa i nā huahana ʻoi aku ka nui o ka nui a me ke koi ʻana i nā kano i ke kaua kūʻē i ka COVID. -19 maʻi maʻi.
He nui nā hoa hana hoʻolālā ʻo Moderna no ka hana hoʻopiha piha. Ma ka US, komo keia Catalent, Inc. (NYSE: CTLT), Baxter BioPharma Solutions a Sanofi (Nasdaq: SNY). Ma waho o ka US, aia kēia ʻO Rovi (BME: ROVI) ma Sepania, ʻO Recipharm ma Farani a Samsung Biologics (KRX: 207940.KS) ma Korea.
No Moderna
I loko o 10 mau makahiki mai kona hoʻomaka ʻana, ua hoʻololi ʻo Moderna mai kahi ʻoihana noiʻi ʻepekema e holomua ana i nā papahana ma ke kahua o ka messenger RNA (mRNA), i kahi ʻoihana me kahi kōpili lāʻau lapaʻau like ʻole o nā kano a me nā therapeutics ma waena o ʻehiku mau ʻano. ma nā wahi e pili ana i ka mRNA a me ka lipid nanoparticle formulation, a me kahi mea kanu i hoʻohui ʻia e hiki ai i ka hana lapaʻau a me ke kālepa ma ka pālākiō a me ka wikiwiki ʻole. Mālama ʻo Moderna i nā kuʻikahi me kahi ākea o nā aupuni kūloko a me nā ʻāina ʻē a me nā mea hana kālepa, i ʻae ʻia no ka ʻimi ʻana i ka ʻepekema groundbreaking a me ka wikiwiki o ka hana ʻana. ʻO ka mea hou loa, ua hui pū nā mana o Moderna e ʻae i ka hoʻohana ʻana i kekahi o nā lāʻau lapaʻau mua loa a maikaʻi loa e kūʻē i ka maʻi maʻi COVID-19.
Kūkulu ʻia ka paepae mRNA o Moderna ma luna o ka holomua mau ʻana i ka ʻepekema mRNA maʻamau, ka ʻenehana lawe ʻana a me ka hana ʻana, a ua ʻae i ka hoʻomohala ʻana i nā lāʻau lapaʻau a me nā lāʻau lapaʻau no nā maʻi infectious, immuno-oncology, nā maʻi laha, nā maʻi cardiovascular a me nā maʻi auto-immune. Ua kapa ʻia ʻo Moderna i mea hana biopharmaceutical kiʻekiʻe e Science no na makahiki ehiku i hala. No ka ʻike hou aku, e kipa www.modernatx.com.
No Samsung Biologics Co., Ltd.
ʻO Samsung Biologics (KRX: 207940.KS) kahi CDMO i hoʻohui piha ʻia e hāʻawi ana i ka hoʻomohala ʻaelike hou, hana, a me nā lawelawe hoʻokolohua. Me nā ʻae hoʻoponopono i hōʻoia ʻia, ka mana nui loa, a me ka wikiwiki wikiwiki, ʻo Samsung Biologics he hoa lanakila i koho ʻia a hiki iā ia ke kākoʻo i ka hoʻomohala ʻana a me ka hana ʻana o nā huahana biologics i kēlā me kēia pae o ke kaʻina ʻoiai e hālāwai ana i nā pono e ulu nei o ka biopharmaceutical. ʻoihana ma ka honua holoʻokoʻa. No ka 'ike hou aku, e kipa www.samsungbiologics.com.
